These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 9766616

  • 1. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV.
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():17-22. PubMed ID: 9766615
    [Abstract] [Full Text] [Related]

  • 6. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM.
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [Abstract] [Full Text] [Related]

  • 7. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
    Glazer WM.
    J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
    [Abstract] [Full Text] [Related]

  • 8. Movement disorders associated with neuroleptic treatment.
    Wirshing WC.
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [Abstract] [Full Text] [Related]

  • 9. The relationship of pharmacology to side effects.
    Casey DE.
    J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
    Miller CH, Mohr F, Umbricht D, Woerner M, Fleischhacker WW, Lieberman JA.
    J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Movement disorders associated with atypical antipsychotic drugs.
    Caroff SN, Mann SC, Campbell EC, Sullivan KA.
    J Clin Psychiatry; 2002 Feb; 63 Suppl 4():12-9. PubMed ID: 11913670
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM, Cellar JS, Bowers MB, Nelson JC, Takeshita J, Zigun B.
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [Abstract] [Full Text] [Related]

  • 16. Side effect profiles of new antipsychotic agents.
    Casey DE.
    J Clin Psychiatry; 1996 Mar; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [Abstract] [Full Text] [Related]

  • 17. Conventional vs. newer antipsychotics in elderly patients.
    Jeste DV, Rockwell E, Harris MJ, Lohr JB, Lacro J.
    Am J Geriatr Psychiatry; 1999 Mar; 7(1):70-6. PubMed ID: 9919323
    [Abstract] [Full Text] [Related]

  • 18. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR, McPhillips MA.
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [Abstract] [Full Text] [Related]

  • 19. Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Carbon M, Kapoor S, Sheridan E, Al-Jadiri A, Azzo S, Sarkaria T, Kane JM, Saito E, Correll CU.
    J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):718-727.e3. PubMed ID: 26299293
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.